Developing enhanced immunotherapy using NKG2A knockout human pluripotent stem cell-derived NK cells
Cell Reports · 2024-11 · 43 (11) · 114867
DOI: 10.1016/j.celrep.2024.114867 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell Reports, 2024-11. Verfasst von Yue Qin und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurodegenerative Diseases, Beckman Research Institute of City of Hope, 1500 E. Duarte Rd., Duarte, CA 91010, USA. Hauptthemen laut MEDLINE: Killer Cells, Natural, NK Cell Lectin-Like Receptor Subfamily C, Immunotherapy, Pluripotent Stem Cells. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 79 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, National Institutes of Health, California Institute for Regenerative Medicine.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurodegenerative Diseases, Beckman Research Institute of City of Hope, 1500 E. Duarte Rd., Duarte, CA 91010, USA.
- Department of Molecular and Medical Pharmacology, University of California, Los Angeles, Los Angeles, CA 90095, USA; Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research, University of California,…
- Department of Pathology, City of Hope National Medical Center, 1500 E. Duarte Rd., Duarte, CA 91010, USA.
- Department of Hematology & Hematopoietic Cell Transplantation, Beckman Research Institute of City of Hope, 1500 E. Duarte Rd., Duarte, CA 91010, USA.
- Department of Neurodegenerative Diseases, Beckman Research Institute of City of Hope, 1500 E. Duarte Rd., Duarte, CA 91010, USA. Electronic address: yshi@coh.org.
Förderung
- NCI NIH HHS
- National Institutes of Health
- California Institute for Regenerative Medicine
- National Cancer Institute
- California Institute of Regenerative Medicine
Zitieren
APA
Qin, Y., Cui, Q., Sun, G., Chao, J., Wang, C., Chen, X., Ye, P., Zhou, T., Jeyachandran, A. V., Sun, O., Liu, W., Yao, S., Palmer, C., Liu, X., Arumugaswami, V., Chan, W. C., Wang, X., & Shi, Y. (2024). Developing enhanced immunotherapy using NKG2A knockout human pluripotent stem cell-derived NK cells. Cell Reports, 43(11), 114867. https://doi.org/10.1016/j.celrep.2024.114867
Vancouver
Qin Y, Cui Q, Sun G, Chao J, Wang C, Chen X, et al. Developing enhanced immunotherapy using NKG2A knockout human pluripotent stem cell-derived NK cells. Cell Reports. 2024;43(11):114867. doi:10.1016/j.celrep.2024.114867
BibTeX
@article{Qin2024,
author = {Qin, Yue and Cui, Qi and Sun, Guihua and Chao, Jianfei and Wang, Cheng and Chen, Xianwei and Ye, Peng and Zhou, Tao and Jeyachandran, Arjit Vijey and Sun, Olivia and Liu, Wei and Yao, Shunyu and Palmer, Chance and Liu, Xuxiang and Arumugaswami, Vaithilingaraja and Chan, Wing C and Wang, Xiuli and Shi, Yanhong},
title = {Developing enhanced immunotherapy using NKG2A knockout human pluripotent stem cell-derived NK cells},
journal = {Cell Reports},
year = {2024},
volume = {43},
number = {11},
pages = {114867},
doi = {10.1016/j.celrep.2024.114867}
}
EUVIMED